Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 16 | 2026 | 409 | 3.710 |
Why?
|
| Ubiquinone | 5 | 2026 | 21 | 2.950 |
Why?
|
| Ammonia | 3 | 2025 | 16 | 1.290 |
Why?
|
| Oxygen | 3 | 2025 | 321 | 1.030 |
Why?
|
| Glycerol | 1 | 2026 | 34 | 0.960 |
Why?
|
| Carnitine | 1 | 2026 | 19 | 0.950 |
Why?
|
| Fumarates | 2 | 2025 | 10 | 0.930 |
Why?
|
| Electron Transport | 2 | 2025 | 29 | 0.930 |
Why?
|
| Electrons | 2 | 2025 | 33 | 0.920 |
Why?
|
| Energy Metabolism | 5 | 2026 | 400 | 0.870 |
Why?
|
| Animals | 31 | 2026 | 21356 | 0.790 |
Why?
|
| Nucleotides | 4 | 2025 | 48 | 0.760 |
Why?
|
| Adipose Tissue, Brown | 4 | 2025 | 125 | 0.700 |
Why?
|
| Mice | 22 | 2026 | 11125 | 0.690 |
Why?
|
| Pyrimidines | 5 | 2025 | 144 | 0.620 |
Why?
|
| Thermogenesis | 4 | 2025 | 128 | 0.570 |
Why?
|
| Adipogenesis | 3 | 2024 | 81 | 0.540 |
Why?
|
| Glutamate Dehydrogenase | 1 | 2017 | 1 | 0.540 |
Why?
|
| Isotope Labeling | 1 | 2017 | 69 | 0.520 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 118 | 0.510 |
Why?
|
| Glutamine | 5 | 2026 | 50 | 0.470 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 295 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 3483 | 0.460 |
Why?
|
| Oxidation-Reduction | 6 | 2024 | 328 | 0.440 |
Why?
|
| Succinate Dehydrogenase | 3 | 2025 | 15 | 0.430 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 4 | 2023 | 55 | 0.420 |
Why?
|
| Mitochondrial Proteins | 3 | 2025 | 109 | 0.410 |
Why?
|
| Neoplasms | 4 | 2026 | 1371 | 0.400 |
Why?
|
| Glutaminase | 2 | 2026 | 5 | 0.370 |
Why?
|
| Cell Proliferation | 4 | 2025 | 1038 | 0.330 |
Why?
|
| Breast Neoplasms | 3 | 2025 | 1232 | 0.330 |
Why?
|
| Cell Line, Tumor | 7 | 2026 | 1566 | 0.320 |
Why?
|
| Liver | 3 | 2025 | 870 | 0.320 |
Why?
|
| Antineoplastic Agents | 4 | 2026 | 643 | 0.310 |
Why?
|
| Cell Differentiation | 3 | 2026 | 1382 | 0.310 |
Why?
|
| Humans | 23 | 2026 | 65385 | 0.310 |
Why?
|
| Caenorhabditis elegans | 3 | 2025 | 703 | 0.310 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2025 | 28 | 0.270 |
Why?
|
| Hypoxia | 2 | 2025 | 120 | 0.250 |
Why?
|
| Glucose | 3 | 2024 | 478 | 0.250 |
Why?
|
| S-Adenosylmethionine | 2 | 2025 | 31 | 0.250 |
Why?
|
| Mosaicism | 1 | 2026 | 29 | 0.240 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2025 | 7 | 0.230 |
Why?
|
| Stress, Physiological | 2 | 2025 | 208 | 0.230 |
Why?
|
| Adipose Tissue | 2 | 2026 | 300 | 0.230 |
Why?
|
| Liver Regeneration | 1 | 2025 | 20 | 0.230 |
Why?
|
| Phosphatidylcholines | 1 | 2025 | 39 | 0.230 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2026 | 62 | 0.230 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2026 | 139 | 0.230 |
Why?
|
| Fragile X Syndrome | 1 | 2026 | 29 | 0.230 |
Why?
|
| Glutarates | 2 | 2022 | 11 | 0.220 |
Why?
|
| Ergothioneine | 1 | 2025 | 1 | 0.220 |
Why?
|
| Sulfurtransferases | 1 | 2025 | 1 | 0.220 |
Why?
|
| Fatty Liver | 1 | 2026 | 110 | 0.220 |
Why?
|
| Metabolic Flux Analysis | 1 | 2025 | 7 | 0.220 |
Why?
|
| Mitochondria, Muscle | 1 | 2025 | 24 | 0.220 |
Why?
|
| Adaptation, Physiological | 1 | 2026 | 131 | 0.220 |
Why?
|
| Metabolomics | 3 | 2025 | 63 | 0.220 |
Why?
|
| Aneuploidy | 1 | 2025 | 42 | 0.220 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2024 | 17 | 0.210 |
Why?
|
| Physical Conditioning, Animal | 1 | 2025 | 47 | 0.210 |
Why?
|
| Apoptosis | 3 | 2024 | 1098 | 0.200 |
Why?
|
| DNA Damage | 2 | 2024 | 298 | 0.200 |
Why?
|
| Kidney | 1 | 2026 | 454 | 0.200 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2026 | 464 | 0.200 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2023 | 9 | 0.200 |
Why?
|
| Signal Transduction | 7 | 2025 | 3148 | 0.200 |
Why?
|
| Selenium | 1 | 2024 | 27 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2026 | 218 | 0.200 |
Why?
|
| Superoxides | 1 | 2023 | 73 | 0.200 |
Why?
|
| Glutamic Acid | 2 | 2026 | 103 | 0.190 |
Why?
|
| Aspartic Acid | 2 | 2025 | 34 | 0.190 |
Why?
|
| Hypertension, Pulmonary | 1 | 2024 | 99 | 0.190 |
Why?
|
| Leucine | 1 | 2022 | 65 | 0.180 |
Why?
|
| Electron Transport Complex III | 1 | 2021 | 5 | 0.180 |
Why?
|
| Electron Transport Complex I | 1 | 2021 | 15 | 0.180 |
Why?
|
| Electron Transport Complex IV | 1 | 2021 | 16 | 0.180 |
Why?
|
| Cell Hypoxia | 1 | 2021 | 42 | 0.180 |
Why?
|
| Obesity | 3 | 2025 | 1272 | 0.180 |
Why?
|
| Mammals | 1 | 2023 | 221 | 0.170 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2021 | 14 | 0.170 |
Why?
|
| Sirtuins | 1 | 2021 | 26 | 0.170 |
Why?
|
| Carcinogenesis | 1 | 2022 | 135 | 0.170 |
Why?
|
| Lipid Metabolism | 1 | 2023 | 224 | 0.170 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2021 | 10 | 0.170 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2025 | 444 | 0.160 |
Why?
|
| Genomics | 1 | 2024 | 385 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2020 | 4 | 0.160 |
Why?
|
| Cell Line | 2 | 2021 | 2024 | 0.160 |
Why?
|
| Fats | 1 | 2020 | 20 | 0.160 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 237 | 0.160 |
Why?
|
| Neurons | 1 | 2026 | 933 | 0.150 |
Why?
|
| Models, Biological | 1 | 2025 | 1192 | 0.150 |
Why?
|
| Histones | 1 | 2023 | 495 | 0.150 |
Why?
|
| Insulin Resistance | 1 | 2022 | 415 | 0.150 |
Why?
|
| Cell Survival | 2 | 2018 | 588 | 0.150 |
Why?
|
| Female | 10 | 2026 | 34146 | 0.150 |
Why?
|
| 3T3-L1 Cells | 3 | 2024 | 90 | 0.140 |
Why?
|
| Homeostasis | 2 | 2018 | 378 | 0.140 |
Why?
|
| Transaminases | 1 | 2018 | 15 | 0.140 |
Why?
|
| Muscle, Skeletal | 2 | 2023 | 787 | 0.140 |
Why?
|
| PPAR gamma | 3 | 2024 | 77 | 0.140 |
Why?
|
| Diet | 1 | 2022 | 536 | 0.140 |
Why?
|
| Succinic Acid | 1 | 2018 | 11 | 0.140 |
Why?
|
| Sirtuin 3 | 1 | 2018 | 11 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 676 | 0.130 |
Why?
|
| Amination | 1 | 2017 | 2 | 0.130 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 191 | 0.130 |
Why?
|
| Indophenol | 1 | 2017 | 1 | 0.130 |
Why?
|
| Glioma | 1 | 2018 | 101 | 0.130 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 65 | 0.130 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 57 | 0.130 |
Why?
|
| Proline | 1 | 2017 | 46 | 0.130 |
Why?
|
| Biocatalysis | 1 | 2017 | 50 | 0.130 |
Why?
|
| Biological Transport | 1 | 2018 | 292 | 0.130 |
Why?
|
| Polymerization | 1 | 2017 | 36 | 0.130 |
Why?
|
| Molecular Structure | 1 | 2017 | 315 | 0.120 |
Why?
|
| Gene Editing | 1 | 2021 | 330 | 0.120 |
Why?
|
| Organelle Biogenesis | 1 | 2016 | 21 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2018 | 317 | 0.120 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 183 | 0.120 |
Why?
|
| Carbon | 1 | 2016 | 52 | 0.120 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2017 | 71 | 0.120 |
Why?
|
| Adipocytes | 3 | 2024 | 274 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 733 | 0.110 |
Why?
|
| Proteome | 1 | 2016 | 152 | 0.110 |
Why?
|
| Citric Acid Cycle | 2 | 2025 | 29 | 0.110 |
Why?
|
| Cell Membrane | 1 | 2017 | 506 | 0.110 |
Why?
|
| Heat-Shock Response | 2 | 2025 | 38 | 0.100 |
Why?
|
| Purines | 2 | 2025 | 43 | 0.100 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 753 | 0.100 |
Why?
|
| Fatty Acids | 2 | 2024 | 199 | 0.100 |
Why?
|
| Amino Acids | 2 | 2025 | 148 | 0.090 |
Why?
|
| Uncoupling Protein 1 | 2 | 2025 | 51 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2025 | 2161 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2026 | 203 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1007 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 982 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2025 | 89 | 0.080 |
Why?
|
| Male | 7 | 2025 | 31147 | 0.080 |
Why?
|
| Adipose Tissue, White | 2 | 2022 | 93 | 0.080 |
Why?
|
| Proteomics | 2 | 2025 | 294 | 0.070 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2026 | 84 | 0.060 |
Why?
|
| Hepatectomy | 1 | 2025 | 63 | 0.060 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2025 | 5 | 0.060 |
Why?
|
| Oxidative Phosphorylation | 1 | 2025 | 43 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2025 | 73 | 0.060 |
Why?
|
| Mammary Glands, Human | 1 | 2025 | 56 | 0.050 |
Why?
|
| Longevity | 1 | 2025 | 117 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2026 | 160 | 0.050 |
Why?
|
| Selenoproteins | 1 | 2024 | 8 | 0.050 |
Why?
|
| Sulfides | 1 | 2024 | 22 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2025 | 180 | 0.050 |
Why?
|
| Uridine Diphosphate Xylose | 1 | 2023 | 6 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2024 | 58 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2025 | 398 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2024 | 100 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2023 | 14 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 96 | 0.050 |
Why?
|
| Swine | 1 | 2024 | 397 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2022 | 33 | 0.050 |
Why?
|
| Receptor, Insulin | 1 | 2022 | 52 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2025 | 412 | 0.050 |
Why?
|
| DNA Replication | 1 | 2024 | 249 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2025 | 961 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 20 | 0.050 |
Why?
|
| Cell Death | 1 | 2024 | 288 | 0.050 |
Why?
|
| Sex Factors | 1 | 2025 | 994 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 314 | 0.040 |
Why?
|
| Myocardium | 1 | 2024 | 302 | 0.040 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2021 | 3 | 0.040 |
Why?
|
| Antimycin A | 1 | 2021 | 3 | 0.040 |
Why?
|
| Oligomycins | 1 | 2021 | 4 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2021 | 10 | 0.040 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2021 | 14 | 0.040 |
Why?
|
| Phenotype | 1 | 2025 | 1233 | 0.040 |
Why?
|
| Mice, Congenic | 1 | 2020 | 22 | 0.040 |
Why?
|
| Culture Media | 1 | 2021 | 78 | 0.040 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 16 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 61 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2022 | 574 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 206 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 85 | 0.040 |
Why?
|
| Gene Expression | 1 | 2023 | 854 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 526 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 285 | 0.040 |
Why?
|
| Insulin | 1 | 2022 | 696 | 0.040 |
Why?
|
| Genome, Human | 1 | 2021 | 237 | 0.040 |
Why?
|
| Pregnancy Proteins | 1 | 2018 | 15 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 617 | 0.040 |
Why?
|
| Lung | 1 | 2024 | 969 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2018 | 36 | 0.030 |
Why?
|
| Azaserine | 1 | 2018 | 1 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 441 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 287 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 59 | 0.030 |
Why?
|
| Isoxazoles | 1 | 2017 | 15 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 369 | 0.030 |
Why?
|
| Cellular Reprogramming | 1 | 2017 | 41 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 373 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 1290 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 700 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2017 | 98 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 422 | 0.030 |
Why?
|
| Epitopes | 1 | 2016 | 291 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 687 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 1588 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1630 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2304 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 641 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 2665 | 0.020 |
Why?
|